Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Uniphar ends year in line with expectations

(Sharecast News) - Pharmaceutical and medical technology service company Uniphar said in an update on Tuesday that its performance in 2023 met its own expectations in terms of gross profit and EBITDA, while also achieving normalised free cash flow conversion in line with medium-term guidance. The AIM-traded firm said it achieved organic gross profit growth exceeding 5% during the year.

It added that it maintained a robust liquidity position, with net debt lower than anticipated at the end of the year.

Looking ahead, Uniphar said it was well-positioned for organic gross profit growth across all of its divisions.

In line with the group's new medium-term targets, it said it aimed to achieve double-digit growth in organic gross profit for Uniphar Pharma in 2024, with high single-digit growth for Uniphar Medtech, and low single-digit growth for Uniphar Supply Chain and Retail.

The company also emphasised that mergers and acquisitions would continue to be a significant part of its growth strategy.

"Today's trading update reflects a strong performance by the group in 2023," said chief executive officer Ger Rabbette.

"Following early delivery on our initial public offering targets, we have created a new divisional structure to capitalise on our attractive growth opportunities and are now focused on reaching our ambitious new target of €200m EBITDA over the medium-term."

Uniphar said it would publish its final results for the year ended 31 December on 27 February.

At 1043 GMT, shares in Uniphar were up 1.49% at 226.32p.

Reporting by Josh White for

Share this article

Related Sharecast Articles

Royal Mail-owner rebuffs takeover approach
(Sharecast News) - Shares in International Distribution Services soared on Wednesday, after it emerged that Czech billionaire Daniel Kretinsky had made a takeover approach for the Royal Mail owner.
Just Eat shares drop as Q1 orders disappoint
(Sharecast News) - Shares in Just Eat dropped sharply on Wednesday after the food delivery marketplace delivered underwhelming order numbers for the first quarter, though revenue growth picked up sharply in the UK and Ireland.
Tekcapital's Innovative Eyewear inks deal with US firm
(Sharecast News) - Intellectual property investor Tekcapital announced a fresh development from its portfolio company Innovative Eyewear on Wednesday, as the latter launched a strategic partnership with Windsor Eyes, a prominent eyewear manufacturing and distribution firm.
Eckoh expanding availability of voice cloud platform
(Sharecast News) - Eckoh announced on Wednesday that it has augmented its global secure voice cloud platform, enhancing its availability and geographic coverage.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.